Search: onr:"swepub:oai:DiVA.org:uu-459242" >
Prognostic role of ...
-
Aasebø, Kristine
(author)
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status : a population-based study of metastatic colorectal cancer patients
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
2021-10-20
-
Springer,2022
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-459242
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459242URI
-
https://doi.org/10.1038/s41416-021-01586-5DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
BACKGROUND: Tumour-infiltrating CD3, CD8 lymphocytes and CD68 macrophages are associated with favourable prognosis in localised colorectal cancer, but the effect in metastatic colorectal cancer (mCRC) is not established.METHODS: A Scandinavian population-based cohort of non-resectable mCRC patients was studied. Tissue microarrays (n = 460) were stained with CD3, CD8 and CD68 using fluorescence-based multiplex immunohistochemistry. Associations with clinicopathological variables, overall survival (OS) and progression-free survival were estimated.RESULTS: Two-thirds of microsatellite instable (MSI) and one-fourth of microsatellite stable (MSS) tumours displayed the highest quartile density of CD8. For CD3 high vs low cases, median OS was 20 vs 16 months (HR: 0.76, 95% CI: 0.59, 0.76, p = 0.025) with 3-year OS of 27 vs 13%. For CD68 high vs low cases, median OS was 23 vs 15 months (HR: 0.69, 95% CI: 0.54, 0.88, p = 0.003) with 3-year OS of 28 vs 12%. MSI, BRAF mutation and CDX2 loss were negative prognostic markers independent of tumour immune infiltration.CONCLUSIONS: In mCRC, high lymphocyte infiltration was found in proportions of MSI and MSS tumours-potential subgroups of immunotherapy response. Tumour-infiltrating CD3 lymphocytes and CD68 macrophages were associated with median and long-term survival. MSI was a significant negative prognostic marker despite high immunogenicity.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Bruun, Jarle
(author)
-
Bergsland, Christian H
(author)
-
Nunes, Luís,1995-Uppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab(Swepub:uu)luinu972
(author)
-
Eide, Geir Egil
(author)
-
Pfeiffer, Per
(author)
-
Dahl, Olav
(author)
-
Glimelius, BengtUppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab(Swepub:uu)bengglim
(author)
-
Lothe, Ragnhild A
(author)
-
Sorbye, Halfdan
(author)
-
Uppsala universitetExperimentell och klinisk onkologi
(creator_code:org_t)
Related titles
-
In:British Journal of Cancer: Springer126:1, s. 48-560007-09201532-1827
Internet link
Find in a library
To the university's database
- By the author/editor
-
Aasebø, Kristine
-
Bruun, Jarle
-
Bergsland, Chris ...
-
Nunes, Luís, 199 ...
-
Eide, Geir Egil
-
Pfeiffer, Per
-
show more...
-
Dahl, Olav
-
Glimelius, Bengt
-
Lothe, Ragnhild ...
-
Sorbye, Halfdan
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
British Journal ...
- By the university
-
Uppsala University